BioSpace News Archive

Genentech, a member of the Roche Group, announced positive top line results from the Roche-sponsored Phase III PEMPHIX study evaluating the efficacy and safety of Rituxan® (rituximab) compared to mycophenolate mofetil (MMF) in adults with moderate to severe pemphigus vulgaris (PV).

First and only non-coated drug-eluting angioplasty balloon that delivers a proprietary bioabsorbable, sustained-release formulation of sirolimus

A Michigan man filed the first lawsuit in Michigan in the Salmonella outbreak linked to pre-cut melons produced by Caito Foods. 22 people contracted Salmonella in this outbreak.

AIDS Healthcare Foundation (AHF) will be joined by Baltimore Mayor Bernard “Jack” Young, State Senator Mary Washington, City Council President Brandon Scott and other members of the Baltimore City Council

Study met primary outcome measure; 63 percent of patients with persistently active RA achieved low disease activity (LDA) as assessed by DAS28-ESR¹ at Week 12

Provention Bio, Inc. announced that it has terminated the public offering of common stock previously announced on June 10, 2019.

AMO Pharma Limited (“AMO Pharma”), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no treatment options, today announced the presentation of results from the Phase 2 clinical trial of AMO-02 during the International Myotonic Dystrophy Consortium Meeting in Gothenburg, Sweden.

Medicenna Therapeutics Corp. announced that it will host a Key Opinion Leader call and webcast for the investment community on Tuesday, June 18, 2019 at 1 PM, EDT.

Mascots from Las Vegas sports teams including the Golden Knights, Aviators, Lights FC, Aces and UNLV teamed up yesterday to welcome the nation’s newest mascot: Miles the Miracle Flights Bear.

Kerecis Limited, the company pioneering the use of fish skin in tissue regeneration, has completed a $16 million Series C funding round.